Regions On Rise: Life Sciences Across US
Pharmaceutical Commerce
AUGUST 11, 2022
Exploring the competitive and unique offerings in three of the US’s lower-cost economic development regions—and how success in these areas has been boosted by COVID.
regions-on-rise-life-sciences-across-us 
106 
Strengthening and transforming the pharmaceutical supply chain
European Pharmaceutical Review
JULY 21, 2023
Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. Globalisation and supply chain complexity are a factor.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Overcoming key barriers to accelerate digital engagement for pharmaceutical organizations
Veeva
MARCH 30, 2023
Digital solutions have become a core focus in the pharmaceuticals and life sciences industry in recent years, with pharmaceutical organizations increasingly keen on alternative ways to communicate and engage with healthcare professionals (HCPs).
15 Top Venture Capital for Biotech Companies
Medico Reach
AUGUST 1, 2022
Most of the rise in transaction volume may be attributed to the increase in transaction sizes as the top firms receive extensive working capital. The firm’s website states that it now has $20 billion in pledged money spread across 16 funds, making it one of the world’s most prominent venture capital organizations.
Top tweets: Covid-19 headed towards seasonality – and more
Pharmaceutical Technology
JULY 22, 2022
Muge Cevik’s tweet on the rise of unusual paediatric hepatitis cases. Helen Branswell’s tweet on the first US monkeypox case. Helen Branswell’s tweet on the first US monkeypox case. The top tweets on infectious diseases in Q2 2022: Top five. Laurie Garrett’s tweet on Covid-19 headed towards seasonality. Username: Laurie Garrett.
Hollywood and the Metaverse’s effect on pharma’s content
pharmaphorum
OCTOBER 3, 2022
“One of our senior clients in big pharma told us, ‘We don’t make pills. Indegene focuses on helping pharma launch its products using technology and compliance frameworks to become 100% compliant, Kapoor explains. “TV used to be very brand-centric. Nobody buys pills. Patients buy stories.
U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare
Clarivate
APRIL 24, 2023
Oak Street has 169 locations across 21 states and expects to nearly double its size to 300 centers by 2026. billion deal to acquire Oak Street Health, a value-based primary-care company focused on treating Medicare patients. That may be at the crux of why Amazon decided to purchase One Medical, closing on the $3.9
Let's personalize your content